Clinical Trials on Chemotherapy-Induced Thrombocytopenia

Total 12329 results

Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

Chemotherapy-Induced Thrombocytopenia
Sobi, Inc.

Completed

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Chemotherapy-induced Thrombocytopenia

United States, China, Hungary, Poland, Russian Federation, Serbia, Ukraine
Beijing Northland Biotech. Co., Ltd.

Completed

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

Chemotherapy-induced Thrombocytopenia

China
BioMAS Ltd

Terminated

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

Chemotherapy Induced Thrombocytopenia

Israel
Qilu Pharmaceutical Co., Ltd.

Recruiting

Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia

China
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia

China
Napolitano Mariasanta
Regione Sicilia

Terminated

Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia (MICE)

Thrombocytopenia | Primary Thrombocytopenia,Unspecified | Thrombocytopenia Chemotherapy Induced

Italy
Jiangsu HengRui Medicine Co., Ltd.

Withdrawn

A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia

Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.

Chemotherapy-Induced Thrombocytopenia

China
Ono Pharma USA Inc

Terminated

A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia

Chemotherapy-Induced Thrombocytopenia

United States, Korea, Republic of, Russian Federation
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaborators

Recruiting

Herombopag for Chemotherapy-induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia | Herombopag

China
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaborators

Recruiting

Avatrombopag for Chemotherapy-induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia | Avatrombopag

China
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaborators

Recruiting

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Eltrombopag | Chemotherapy-induced Thrombocytopenia

China
Angde Biotech Pharmaceutical Co., Ltd.

Unknown

A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

Chemotherapy-induced Thrombocytopenia

China
Sichuan Clover Biopharmaceuticals, Inc.

Recruiting

A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)

Chemotherapy-induced Thrombocytopenia (CIT)

China
Memorial Sloan Kettering Cancer Center
Amgen

Completed

Study of Romiplostim for Chemotherapy Induced Thrombocytopenia

Isolated Chemotherapy-induced Thrombocytopenia

United States
Ain Shams University

Recruiting

Romiplostim in Chemotherapy-Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia | Solid Malignancy

Egypt
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies

Chemotherapy-induced Thrombocytopenia
Amgen

Withdrawn

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.

Chemotherapy-induced Thrombocytopenia
Veralox Therapeutics

Recruiting

A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Heparin Induced Thrombocytopenia | Thrombocytopenia, Immune

United States
Beth Israel Medical Center

Completed

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Immune Thrombocytopenia | Myelodysplasia | Chemotherapy Induced Thrombocytopenia | Aplastic Anaemia

United States
Sun Yat-sen University

Not yet recruiting

Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma

Chemotherapy-Induced Thrombocytopenia
Liaoning Tumor Hospital & Institute

Completed

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

Chemotherapy-induced Thrombocytopenia

China
GlaxoSmithKline

Withdrawn

A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

Purpura, Thrombocytopaenic, Idiopathic
Hanny Al-Samkari, MD
Swedish Orphan Biovitrum

Recruiting

Avatrombopag vs. Placebo for CIT in GI Malignancies (ACT-GI)

Gastrointestinal Neoplasms | Gastrointestinal Cancer | Chemotherapy-Induced Thrombocytopenia

United States
Amgen

Completed

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Thrombocytopenia | Immune Thrombocytopenia | Idiopathic Thrombocytopenic Purpura | Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenic Purpura

United States, Canada, Australia
RenJi Hospital
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia (H-CIT-AML)

Chemotherapy-Induced Thrombocytopenia
Assistance Publique Hopitaux De Marseille

Completed

NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults

Immunologic Thrombcytopenic Purpura (ITP) Adults

France
Sohag University

Recruiting

Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP) (microRNAITP)

Primary Immune Thrombocytopenia

Egypt
GlaxoSmithKline

Completed

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) (PETIT)

Purpura, Thrombocytopaenic, Idiopathic

United States, France, Netherlands, Spain, United Kingdom, Canada
GlaxoSmithKline

Completed

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag (RAISE)

Purpura, Thrombocytopaenic, Idiopathic

United States, Taiwan, Italy, Poland, Peru, Canada, Denmark, Germany, Slovakia, Spain, United Kingdom, New Zealand, China, Greece, Hong Kong, Russian Federation, Austria, Netherlands, Czech Republic, France, India, Ukraine, Tunisia, F... and more
GlaxoSmithKline

Completed

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Purpura, Thrombocytopaenic, Idiopathic

Germany, Russian Federation
Assiut University
Association for Training, Education, and Research in Hematology, Immunology...

Not yet recruiting

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

ITP - Immune Thrombocytopenia
Amgen

Completed

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

Idiopathic Thrombocytopenic Purpura | Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
GlaxoSmithKline

Completed

Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect

Purpura, Thrombocytopaenic, Idiopathic

United States
Central Hospital, Nancy, France

Recruiting

Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery (TicTac)

Heparin-induced Thrombocytopenia

France
Centre Hospitalier Universitaire de Besancon

Not yet recruiting

Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care. (REPROHEP)

Heparin-induced Thrombocytopenia
University of Arizona
American College of Clinical Pharmacy

Recruiting

Pharmacogenomics of Heparin-Induced Thrombocytopenia (PHIT)

Heparin-induced Thrombocytopenia

United States
Veralox Therapeutics
Celerion

Completed

A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects

Heparin-induced Thrombocytopenia

United States
Aspen Global Incorporated

Terminated

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban (HITSOVA)

Heparin-induced Thrombocytopenia

United States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
Marshall University

Unknown

Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) (HIT)

Heparin-induced Thrombocytopenia

United States
GlaxoSmithKline

Completed

Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag

Purpura, Thrombocytopaenic, Idiopathic

United Kingdom
GlaxoSmithKline

Completed

Promacta Pregnancy Registry

Purpura, Thrombocytopaenic, Idiopathic
Ottawa Hospital Research Institute

Unknown

Optimizing the Diagnosis of Heparin Induced Thrombocytopenia (HIT)

Heparin-induced Thrombocytopenia (HIT)

Canada
GlaxoSmithKline

Completed

LENS - Long-term Eltrombopag Observational Study (LENS)

Purpura, Thrombocytopaenic, Idiopathic

United States, Bulgaria, Italy, Peru, Russian Federation, Canada, France, Germany, Hong Kong, Spain, Sweden, United Kingdom, Hungary, Poland, Ukraine, Czech Republic, India, Australia, Tunisia, Puerto Rico, Pakistan
CHIR-Net
University Medicine Greifswald

Completed

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients (HITOLT)

Liver Transplantation | Heparin-induced Thrombocytopenia

Germany
Vanderbilt University Medical Center
American Heart Association

Completed

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

Heparin-induced Thrombocytopenia

United States
Central Hospital, Nancy, France

Completed

Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation (TIH ECMO)

Heparin-induced Thrombocytopenia
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study (HIT-RADIO)

Heparin Induced Thrombocytopenia

United States
David Gomez Almaguer

Unknown

Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Thrombotic Thrombocytopenic Purpura | Immune Thrombocytopenia

Mexico

Clinical Trials on Chemotherapy-Induced Thrombocytopenia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations